Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.15 M
About Histogen Inc.
Sector
Industry
CEO
Susan A. Knudson
Website
Headquarters
San Diego
Founded
2005
Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It focuses on Human Multipotent Cell Conditioned Media, Human Extracellular Matrix, and Hair Stimulating Complex. The company was founded by Steven J. Mento and Gail K. Naughton on July 13, 2005 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on LS exchange Histogen Inc. stocks are traded under the ticker A3DMJS.
Yes, you can track Histogen Inc. financials in yearly and quarterly reports right on TradingView.
Histogen Inc. is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
No, A3DMJS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, A3DMJS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Histogen Inc. stock right from TradingView charts — choose your broker and connect to your account.